SLC5A7 and Alzheimer disease: Mutations in SLC5A7 have been shown to underlie the dysfunction of cholinergic neurotransmission, which might lead to pathogenesis, including Alzheimer’s disease (AD), myasthenia, cardiovascular disorders, depression, and attention-deficit/hyperactivity disorder (ADHD) [24–27].